ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 149 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q3 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $42,615,484 | -25.1% | 1,667,925 | -15.9% | 0.00% | -33.3% |
| Q2 2023 | $56,905,938 | +6.1% | 1,984,168 | -11.3% | 0.00% | 0.0% |
| Q1 2023 | $53,644,836 | -30.0% | 2,237,999 | -50.4% | 0.00% | +50.0% |
| Q4 2022 | $76,586,136 | +89.3% | 4,515,692 | +65.4% | 0.00% | -33.3% |
| Q3 2022 | $40,465,000 | -8.4% | 2,730,462 | -2.7% | 0.00% | 0.0% |
| Q2 2022 | $44,181,000 | -49.1% | 2,806,918 | -12.8% | 0.00% | -25.0% |
| Q1 2022 | $86,756,000 | +14.0% | 3,217,957 | +56.5% | 0.00% | 0.0% |
| Q4 2021 | $76,095,000 | +8.3% | 2,056,074 | +39.8% | 0.00% | 0.0% |
| Q3 2021 | $70,253,000 | +18.2% | 1,470,341 | -16.3% | 0.00% | +33.3% |
| Q2 2021 | $59,411,000 | +2.9% | 1,755,654 | +25.6% | 0.00% | 0.0% |
| Q1 2021 | $57,739,000 | +31.5% | 1,398,035 | +38.2% | 0.00% | 0.0% |
| Q4 2020 | $43,897,000 | -34.4% | 1,011,919 | -35.1% | 0.00% | -40.0% |
| Q3 2020 | $66,935,000 | +455.0% | 1,560,254 | +504.7% | 0.01% | +400.0% |
| Q2 2020 | $12,060,000 | – | 258,022 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DFPG INVESTMENTS, LLC | 183,803 | $9,359,000 | 5.00% |
| DAFNA Capital Management LLC | 229,652 | $9,852,000 | 3.20% |
| HealthCor Management, L.P. | 1,594,452 | $68,402,000 | 2.74% |
| Capital Impact Advisors, LLC | 110,000 | $4,719,000 | 1.40% |
| Cormorant Asset Management, LP | 700,000 | $30,030,000 | 1.16% |
| ARK Investment Management | 2,495,842 | $107,072,000 | 0.64% |
| Millrace Asset Group, Inc. | 18,087 | $776,000 | 0.63% |
| COOPER CREEK PARTNERS MANAGEMENT LLC | 50,532 | $2,168,000 | 0.54% |
| Endurant Capital Management LP | 34,485 | $1,479,000 | 0.44% |
| HealthCor Management, L.P. | 200,000 | $8,580,000 | 0.34% |